Lung Cancer News and Research

Latest Lung Cancer News and Research

Gene expression test could help determine who needs more aggressive treatment

Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment.

21 Jul 2008

Colorectal cancer screening rates still too low

Although colorectal cancer screening tests are proven to reduce colorectal cancer mortality, only about half of U.S. men and women 50 and older receive the recommended tests, according to a report in the July 2008 issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

14 Jul 2008

46 percent of Americans show biologic exposure to the deadly toxins found in cigarettes

A new report issued today by the Centers for Disease Control (CDC) exemplifies the need for nonsmoking Americans to be better protected against exposure to secondhand smoke. The report finds that 46 percent of Americans show biologic exposure to the deadly toxins found in cigarettes. Even more startling are the millions of children this statistic includes.

10 Jul 2008

Nanomaterials key to new strategies for blocking metastasis

A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.

9 Jul 2008

Circulating tumor cells can reveal genetic signature of dangerous lung cancers

Using a miniature laboratory-on-a-chip device, a team of investigators at the Massachusetts General Hospital, led by Daniel Haber, M.D., Ph.D., and Mehmet Toner, Ph.D., both members of the MIT-Harvard Center for Cancer Nanotechnology Excellence (CCNE), has developed a method that detects and analyzes the genetic signature of rare tumor cells in the bloodstream.

9 Jul 2008

Cigarette smoking leads to bladder cancer - need for more awareness

Even though cigarette smoking accounts for up to half of all bladder cancer cases, few people are aware of the connection - including more than three-quarters of patients who have bladder cancer, according to a new study from the University of Michigan Comprehensive Cancer Center.

8 Jul 2008

AMDL granted FDA clearance to market blood test for colorectal cancer

AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).

7 Jul 2008

Microchip-based device determines the genetic signature of lung tumors

Massachusetts General Hospital (MGH) investigators have shown that an MGH-developed, microchip-based device that detects and analyzes tumor cells in the bloodstream can be used to determine the genetic signature of lung tumors, allowing identification of those appropriate for targeted treatment and monitoring genetic changes that occur during therapy. A pilot study of the device called the CTC-chip will appear in the July 24 New England Journal of Medicine and is receiving early online release.

3 Jul 2008

Cancer cases up but survival more than doubles in breast and bowel cancer

The number of people surviving some of the most common types of cancer for at least five years has doubled since the National Health Service was founded 60 years ago.

3 Jul 2008

Report says cancer clinicians should understand and consider the economic impact of new interventions

Cancer clinicians should understand and consider the economic impact of new interventions, which often have substantial costs, according to a report appearing in the July/August issue of CA: A Cancer Journal for Clinicians, a peer-reviewed journal of the American Cancer Society.

2 Jul 2008

Smoking ban triggered the biggest fall in smoking ever seen in England

Smokefree law in England has helped more smokers to quit than ever before and will help prevent an estimated 40,000 deaths over the next 10 years - according to new research being presented in Birmingham tomorrow (Tuesday).

30 Jun 2008

Faulty DNA repair could be a risk factor for lung cancer in nonsmokers

People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center.

26 Jun 2008

New clinical trial for patients with asbestos-associated lung cancer

The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos.

26 Jun 2008

First comprehensive report on colorectal cancer care in Europe and Australia reveals need for action

The first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients diagnosed with this common cancer in Europe and Australia.

25 Jun 2008

Noninvasive molecular imaging technology helps track stem cells in tumors

Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms, according to researchers at the Society of Nuclear Medicine's 55th Annual Meeting. This ability could lead to major advances in the use of stem cell therapies to treat cancer.

16 Jun 2008

Advanced cancer patients often unaware of life expectancies, effects of chemotherapy, according to perspective

Patients with advanced cancer often are not aware of their life expectancies or the effect that chemotherapy will have on their lives, according to a perspective published on Wednesday in the Journal of the American Medical Association, USA Today reports.

11 Jun 2008

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen Ltd. announced today the discovery of more than ten novel targets of antibody therapy for various types of solid and hematopoietic cancer.

11 Jun 2008

The risk of death by age, sex, and smoking status in the U.S.

Researchers have updated charts that show an American's risk of dying from a given cause over the next ten years, based on age, sex, and smoking status. The charts will be published online June 10 in the Journal of the National Cancer Institute.

11 Jun 2008

Computed tomography lung cancer screening no cure-all for smokers

Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current and former smokers, but it won't protect them from other causes of death associated with smoking, according to a new study published in the July issue of the journal Radiology.

11 Jun 2008